Jaguar Land Rover has revealed its bid to combat car sickness with a system that uses biometric sensors to identify how well each passenger is feeling and automatically personalises the car’s cabin settings in response. This solution, if found to be effective, could prove especially useful in the autonomous cars of the future, whose passengers are likely to spend a lot of time reading or working.
Seven people out of ten suffer from motion sickness, a recurring problem that Jaguar Land Rover is trying to find a cure for, as reported by Autoconnectedcar.com. The carmaker has developed a system with an algorithm that generates a ‘wellness score’ for each passenger and can be used to automatically personalise a vehicle’s driving and cabin settings. As a result, the effects of feeling car sick can be reduced by up to 60%.
Spencer Salter, wellness technology researcher Jaguar Land Rover, said that little has been known about the causes of motion sickness and ways of combating it. The ailment often occurs when the eyes observe information that is different to what is sensed by the rest of the body, when the passenger is reading, for example.
“As we move towards an autonomous future where occupants will have more time to either work, read or relax on longer journeys, it’s important we develop vehicles that can adapt to reduce the effects of motion sickness in a way that’s tailored to each passenger,” explained Salter.
Jaguar’s wellness score is generated with the use of biometric sensors that record physiological signals. The data is then analysed and processed in real time. Dr Steve Iley, Jaguar Land Rover Chief Medical Officer explained that it is a scientifically reliable solution that will greatly improve the quality of car journeys.
The first phase of research will reach its conclusion in November, with further developments to be added to the existing technology already used by Jaguar Land Rover to combat nausea, such as a seat with 26 different configurations and the Adaptative Dynamics system, which reduces road vibrations.
Contact Allianz Partners
Apr 3, 2018
Versa, Fitbit’s latest smartwatch, allows users to track their menstrual cycles. Connected to a mobile app, the watch’s algorithm offers women cycle predictions and helps them gauge [...]
Jun 9, 2017
A recent Allianz Worldwide Partner survey carried out among its policy-holders showed that the majority of users of MyHealthApp, the group's app for healthcare on the go, rated the app [...]
Dec 5, 2017
The US Food and Drug Administration recently authorised the sale of Abilify MyCite – the first ever electronic drug, sold by a Japanese laboratory and which works in conjunction with [...]